Thursday September 9, 2010
![]() |
Mr. Martell K. Winters, B.S. RM/SM (NRM)
Senior Scientist
Nelson Laboratories Inc.
|
![]() |
Martell Winters B.S. RM/SM (NRM), is currently a senior scientist at Nelson Laboratories, Inc. In addition to being the AATB liaison to the AAMI Radiation Working Group, Martell also participates in multiple task forces from the AAMI working group organized to draft new procedures (e.g. VDmax, sterilization of tissue).
Martell has presented at AATB meetings as well as national and international conferences (IMRP, IAEA) regarding microbiological culturing, bioburden, radiation sterilization, and sterility assurance levels.
Martell was responsible for the development of the AAMI TIR on Radiation Sterilization of Human Tissue-based Products and is currently involved in developing the ISO standard on Aseptic Processing of Solid Medical Devices. He has assisted the International Irradiation Association (iiA) in preparing a seminar on radiation sterilization of small and large molecules.
Dr. Carolyn Broughton
Scientist
Technology & Methods Management
Genetech, Inc |
Carolyn Broughton, PhD, is currently a Scientist in Technology & Methods Management at Genentech, Inc. Her responsibilities include collaborative and contract projects for both clinical and commercial products. She has more than twenty years experience managing microbiology laboratories in the biotechnology, pharmaceutical and cosmetics industries. She received her PhD in Microbiology from North Carolina State University.
Mr. Kenneth Christie
Chief Operating Officer
VTS Consultants
|
![]() |
Kenneth Christie has over 30 years of sterile manufacturing and regulatory consulting experience in the areas of Quality Assurance and Validation Management in the pharmaceutical and biotechnology industries. Mr. Christie is currently the Chief Operating Officer for VTS Consultants, Inc located in Amhesrt, MA. Specifically, his responsibilities include quality system auditing, GMP training, and serving as a subject matter expert for aseptic and solid dosage processing equipment, utilities, and systems on a global basis.
Prior to joining VTS, Mr. Christie was the Validation Manager at Parke-Davis' Sterile Products Facility in Rochester, MI. While there, he was involved in the review and approval of all facility, equipment, and system commissioning/qualification activities. Additional responsibilities included routine interaction with the FDA and European inspectors, corporate management and third party contract-manufacturing representatives to defend validation practices and to assure regulatory compliance for the manufacture of aseptically produced products.
Mr. Christie is a speaker and trainer for several professional organizations in the US, Canada, Europe, and Asia and is a published author of several articles dealing with the challenges of aseptic processing. Additionally, Mr. Christie serves as a member of the ISPE’s Professional Certification (PCC) Commission as an Examination Development Committee (EDC) member.
He possesses a BS degree in Biology from Shippensburg State University (PA) and an Executive MBA degree from Michigan State.
Mr. Austin McDonald
Sr. Engineer
Project Manager
Sterile Technology LLC |
Austin McDonald is a Sr. Engineer / Project Manager at Sterile Technology LLC, located in Wilmington Delaware. With 20 years in the pharmaceutical industry, Austin has extensive experience supporting clients in the design, construction, qualification and operation of sterile manufacturing processes and facilities. Austin’s specialist areas are Regulatory & Quality, manufacturing operations, barrier isolator systems, sterilization (H2O2, steam & gamma), sterile component handling, sterile filling of vials & syringes, lyophilization & loading systems, automated inspection systems and the handling of complex materials including, cytotoxic substances, carcinogenic substances, biological hazards & radioactive pharmaceuticals. In addition to speaking at numerous conferences on aseptic processing and isolation technology, Austin is an Adjunct Professor at Stevens Institute of Technology, NJ, where he lectures on the project management, design and implementation of advanced aseptic processes. Prior to Sterile Technology, Austin was a Principal Engineer and Managing Partner at GL Engineering, Livingston NJ, Director of Barrier Technology at Kvaerner Process, Bridgewater NJ, and a Director at the Tanshire Group, Elstead, Surrey, UK (now Bovis Lend Lease).
Mr. Jim Polarine Jr., MA.
Formulated Chemistries
Technical Service Specialist
STERIS Corporation |
![]() |
Mr. Polarine is a technical service specialist at STERIS Corporation. He has been with STERIS Corporation for over nine years, where his current technical focus is microbial control in cleanrooms and other critical environments. He has lectured in North America, Europe, Asia, Latin America, and Puerto Rico on issues related to cleaning and disinfection in cleanrooms. Mr. Polarine is a frequent industry speaker and has worked on several books and article publications related to cleaning and disinfection and contamination control. He is currently co-authoring several articles and is an author on the PDA technical report on cleaning and disinfection. He is also currently active on the PDA task force on cleaning and disinfection. He is part of the faculty at the University of Tennessee Parenteral Medication course. He has presented at key industry events for PDA, ISPE, AALAS, IVT, University of Tennessee, SWE, and Barnett International on cleaning and disinfection and contamination control. Mr. Polarine also frequently presents global industry webinars on Cleaning and Disinfection including one that he co-presents with Carole Genovesi (Cleanroom Manager at Genentech). Mr. Polarine graduated from the University of Illinois with a Master of Arts in Biology, and is a member of the PDA, ISPE, IEST, ASM, AALAS, ASTM, AAAS, AOAC, and ACS. He previously worked as a clinical research coordinator with the Department of Veteran’s Affairs and as a biology and microbiology instructor at the University of Illinois. His main hobby is storm chasing and is very active in tornado research and tornado safety.
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
| The Basics of Aseptic Processing…and How Best to Manage Them |
|
| Sterility Testing Programs – Regulatory Requirements and Reality |
|
| Defining Common Methods of Sterilization |
|
| Sterilization practices for drugs, devices and lab research markets |
Sterility assurance monitoring tools and practices
|
| Investigating sterility failures |
|
| Fundamentals of Sterilization Validation |
|
| Strategies for Investigating Sterility Failures for Regulated Manufacturing Facilities |
|
| Conducting a media fill failure investigation |
Interactive Exercise: The group will analyze data from a failed media fill, develop an investigation plan, and propose corrective actions. |
| Aseptic Processing Equipment |
This presentation will outline the considerations when selecting equipment and suppliers for aseptic processing process equipment for aseptic vial filling / lyophilization & inspection and aseptic syringe filling & inspection.
|
| Design, Procurement, Acceptance Testing And Qualification Of Aseptic Processing Equipment |
This presentation will outline the key steps associated with the design, procurement, acceptance testing and qualification of aseptic processing equipment undertaken within a modified GAMP structure, and how this methodology is used to help minimize the technical challenges, cost and schedule overruns typically associated with implementing complex aseptic manufacturing processes. This presentation will address the following:
|
This two day course and workshops is directed toward Directors, Managers, Supervisors, Analysts and Associates in the Pharmaceutical, Biopharmaceutical, Biotechnology and allied industries with daily responsibilities in the following areas:
Registration Fee Includes: Presentation Materials, Luncheon, and Refreshments
Cancellation/Substitutions Policy:
All cancellations are subject to a USD $150.00/person processing fee. To receive cancellation credits for attendance at an upcoming course, IPA must be notified of the cancellation in writing (by email, mail or fax) up to 3 weeks prior to the program start date. Cancellations submitted less than 3 weeks prior to the event will not be qualified for refund or credit. Substitution of delegate/s with the member/s of the same organization is permitted at any time with no penalty.
IPA reserves the right to postpone an event, prior to which time all the registered attendees will be notified a minimum of 2 weeks in advance. IPA shall not be responsible for any air fare, hotel or transportation costs incurred by registrant/s.
Hilton Philadelphia Airport
4509 Island Avenue, Philadelphia,
Pennsylvania, United States 19153
Tel: 1-215-365-4150 Fax: 1-215-937-6382